Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
$110,000 53.3%
Total revenue, Q2 '26 ().

Did Cocrystal Pharma Beat Earnings?

Cocrystal Pharma (COCP) reported Q2 '26 revenue of $110,000.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Cocrystal Pharma’s job postings, web traffic, and employee business outlook. See the full COCP stock analysis or the earnings calendar for upcoming reports.

Cocrystal Pharma Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue—140,000————230,000110,000
Gross margin—-20.6%————59.6%100.0%
Operating margin—-2,375.0%————-1,047.1%-3,032.4%
Net income-4.9M-3.3M-2.3M-2.1M-2M-2.4M-2.3M-3.2M
Net margin—-2,401.5%————-1,021.8%-3,013.3%
EPS————————

Cocrystal Pharma Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Cocrystal Pharma’s quarterly revenue moved from $0 to $110,000.

When Is Cocrystal Pharma’s Next Earnings Date?

Cocrystal Pharma reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the COCP earnings calendar.

Frequently Asked Questions: Cocrystal Pharma Earnings

Cocrystal Pharma's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Cocrystal Pharma reported Q2 '26 revenue of $110,000.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the COCP AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.